SREBF1 and metabolic dysfunction-associated steatohepatitis: Meanwhile, hyperinsulinemia and hyperglycemia in NASH patients may activate sterol-regulatory element binding protein 1c (Srebp1c) and carbohydrate response element binding protein (Chrebp), respectively, to activate DNL-related gene expression in the liver.81